...
search icon
mdxg-img

MiMedx Group Inc Share Price

MDXG
NAQ
$5.12
+$0.03
(0.59%)
1D
Industry: Biotechnology Sector: Health Care

MiMedx Group Inc Analyst Forecast

MiMedx Group Inc Share Price Chart

MiMedx Group Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$753.84M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
18.8519
Volume info-icon
This is the total number of shares traded during the most recent trading day.
515.06K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.59
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.89 L
$8.54 H
$5.12

About MiMedx Group Inc, Common Stock

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia. more

Industry: BiotechnologySector: Health Care

MiMedx Group Inc Stock Returns

Time FrameMDXGSectorS&P500
1-Week Return-0.58%-1.08%-1.38%
1-Month Return-12.93%-0.47%-1.81%
3-Month Return-31.46%2.13%1.38%
6-Month Return-29.57%17.04%5.68%
1-Year Return-38.16%6.56%11.74%
3-Year Return10.82%16.78%65.15%
5-Year Return-46.89%34.34%73.68%
10-Year Return-35.19%137.88%260.03%

MiMedx Group Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue248.23M242.02M267.84M321.48M348.88M[{"date":"2020-12-31","value":71.15,"profit":true},{"date":"2021-12-31","value":69.37,"profit":true},{"date":"2022-12-31","value":76.77,"profit":true},{"date":"2023-12-31","value":92.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue39.33M39.63M48.32M54.63M60.07M[{"date":"2020-12-31","value":65.47,"profit":true},{"date":"2021-12-31","value":65.97,"profit":true},{"date":"2022-12-31","value":80.43,"profit":true},{"date":"2023-12-31","value":90.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit208.90M202.39M219.53M266.84M288.81M[{"date":"2020-12-31","value":72.33,"profit":true},{"date":"2021-12-31","value":70.08,"profit":true},{"date":"2022-12-31","value":76.01,"profit":true},{"date":"2023-12-31","value":92.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin84.16%83.63%81.96%83.01%82.78%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.37,"profit":true},{"date":"2022-12-31","value":97.39,"profit":true},{"date":"2023-12-31","value":98.63,"profit":true},{"date":"2024-12-31","value":98.37,"profit":true}]
Operating Expenses254.30M209.44M234.25M229.73M229.94M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.36,"profit":true},{"date":"2022-12-31","value":92.12,"profit":true},{"date":"2023-12-31","value":90.34,"profit":true},{"date":"2024-12-31","value":90.42,"profit":true}]
Operating Income(45.40M)(7.05M)(14.73M)37.12M58.87M[{"date":"2020-12-31","value":-77.12,"profit":false},{"date":"2021-12-31","value":-11.98,"profit":false},{"date":"2022-12-31","value":-25.02,"profit":false},{"date":"2023-12-31","value":63.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(24.09M)(9.98M)(10.04M)(12.80M)(2.58M)[{"date":"2020-12-31","value":-2408600000,"profit":false},{"date":"2021-12-31","value":-998300000,"profit":false},{"date":"2022-12-31","value":-1003600000,"profit":false},{"date":"2023-12-31","value":-1279700000,"profit":false},{"date":"2024-12-31","value":-257700000,"profit":false}]
Pre-Tax Income(61.54M)(12.05M)(19.75M)30.63M57.29M[{"date":"2020-12-31","value":-107.42,"profit":false},{"date":"2021-12-31","value":-21.04,"profit":false},{"date":"2022-12-31","value":-34.47,"profit":false},{"date":"2023-12-31","value":53.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(12.26M)247.00K206.00K(36.81M)15.30M[{"date":"2020-12-31","value":-80.15,"profit":false},{"date":"2021-12-31","value":1.61,"profit":true},{"date":"2022-12-31","value":1.35,"profit":true},{"date":"2023-12-31","value":-240.63,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(49.28M)(12.30M)(19.95M)67.44M42.00M[{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-18.24,"profit":false},{"date":"2022-12-31","value":-29.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":62.28,"profit":true}]
Income From Continuous Operations(49.28M)(10.29M)(30.20M)4.34M42.00M[{"date":"2020-12-31","value":-117.35,"profit":false},{"date":"2021-12-31","value":-24.49,"profit":false},{"date":"2022-12-31","value":-71.9,"profit":false},{"date":"2023-12-31","value":10.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(49.28M)(12.30M)(30.20M)67.44M42.42M[{"date":"2020-12-31","value":-73.08,"profit":false},{"date":"2021-12-31","value":-18.24,"profit":false},{"date":"2022-12-31","value":-44.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":62.9,"profit":true}]
EPS (Diluted)(0.05)(0.15)(0.33)0.320.31[{"date":"2020-12-31","value":-15.85,"profit":false},{"date":"2021-12-31","value":-47.56,"profit":false},{"date":"2022-12-31","value":-104.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.29,"profit":true}]

MiMedx Group Inc Ratios

MiMedx Group Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MDXG
Cash Ratio 2.46
Current Ratio 4.41
Quick Ratio 3.95

MiMedx Group Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MDXG
ROA (LTM) 11.98%
ROE (LTM) 19.44%

MiMedx Group Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MDXG
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

MiMedx Group Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MDXG
Trailing PE 18.85
Forward PE 19.53
P/S (TTM) 1.92
P/B 3.23
Price/FCF 30
EV/R 1.65
EV/Ebitda 9.48
PEG 2.97

FAQs

What is MiMedx Group Inc share price today?

MiMedx Group Inc (MDXG) share price today is $5.12

Can Indians buy MiMedx Group Inc shares?

Yes, Indians can buy shares of MiMedx Group Inc (MDXG) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MDXG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MiMedx Group Inc be purchased?

Yes, you can purchase fractional shares of MiMedx Group Inc (MDXG) via the Vested app. You can start investing in MiMedx Group Inc (MDXG) with a minimum investment of $1.

How to invest in MiMedx Group Inc shares from India?

You can invest in shares of MiMedx Group Inc (MDXG) via Vested in three simple steps:

  • Click on Sign Up or Invest in MDXG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MiMedx Group Inc shares
What is MiMedx Group Inc 52-week high and low stock price?

The 52-week high price of MiMedx Group Inc (MDXG) is $8.54. The 52-week low price of MiMedx Group Inc (MDXG) is $4.89.

What is MiMedx Group Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MiMedx Group Inc (MDXG) is 18.8519

What is MiMedx Group Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MiMedx Group Inc (MDXG) is 3.23

What is MiMedx Group Inc dividend yield?

The dividend yield of MiMedx Group Inc (MDXG) is 0.00%

What is the Market Cap of MiMedx Group Inc?

The market capitalization of MiMedx Group Inc (MDXG) is $753.84M

What is MiMedx Group Inc's stock symbol?

The stock symbol (or ticker) of MiMedx Group Inc is MDXG

How Can Investors Use MiMedx Group Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of MiMedx Group Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether MiMedx Group Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from MiMedx Group Inc shares for Indian investors?

When investing in MiMedx Group Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the MiMedx Group Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare MiMedx Group Inc share price with other stocks in the same sector?

Rather than merely checking the share price of MiMedx Group Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that MiMedx Group Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top